Colorectal Cancer Trial, Recruiting NCT06272461 Sponsor: University Tunis El Manar Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06272461
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older.
  • People whose overall health before surgery is assessed by an anaesthesiologist as being in a low-to-moderate risk category (known as ASA physical status I, II, or III).
  • People who are scheduled for a planned (non-emergency) open bowel or colon surgery.

Who may not be able to join:

  • People who have a known medical reason why they cannot receive the medications lidocaine or ketamine.
  • People who have taken corticosteroid (steroid) medications at any point in the last 6 months.
  • People with a history of taking medications that suppress the immune system.
  • People who have had any surgery in the last 3 months.
  • People who have a personal history of inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
  • People who have a personal history of irregular heartbeats or problems with the heart's electrical system.
  • People with a history of alcohol or drug misuse.
  • People who regularly use opioid pain medications or benzodiazepine (sedative/anxiety) medications.
  • People who experience serious complications during surgery (confirm with trial site).
  • People whose surgery lasts longer than 5 hours.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: BEN ALI MECHAAL, Professor, university manar Tunis, Tunisia

Phone: 72100533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Tunis El Manar
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
10 February 2026

Where this trial is recruiting

Tunisia

Primary endpoints

The variation of Interleukin-6 levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov